1. Home
  2. REI vs RPID Comparison

REI vs RPID Comparison

Compare REI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ring Energy Inc.

REI

Ring Energy Inc.

HOLD

Current Price

$1.33

Market Cap

181.3M

Sector

Energy

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$2.23

Market Cap

204.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REI
RPID
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.3M
204.3M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
REI
RPID
Price
$1.33
$2.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
5.4M
223.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
$307,178,072.00
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
$10.17
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$0.72
$2.01
52 Week High
$1.65
$4.94

Technical Indicators

Market Signals
Indicator
REI
RPID
Relative Strength Index (RSI) 41.82 38.81
Support Level $1.22 $2.01
Resistance Level $1.64 $2.43
Average True Range (ATR) 0.08 0.19
MACD -0.03 0.07
Stochastic Oscillator 12.16 48.12

Price Performance

Historical Comparison
REI
RPID

About REI Ring Energy Inc.

Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: